Blog

With over 20 years of artificial intelligence innovation and experience, iCAD was the first to introduce an FDA-cleared AI solution for Digital Breast Tomosynthesis (DBT) in 2016. ProFound Detection V4.0 now extends that pioneering legacy to its fourth generation AI using the latest in deep learning neural network technologies, offering...

In an era where technology continuously redefines healthcare, radiologists and breast imaging professionals face the critical task of detecting breast cancer early and more accurately, avoiding the pitfalls of a missed or delayed diagnosis of cancer. Artificial intelligence (AI) is revolutionizing breast cancer detection by providing radiologists with powerful tools...

ProFound AI Detection delivers clarity, confidence, and peace of mind. ProFound is clinically proven to improve breast cancer detection and radiologist performance. FDA Cleared. CE Marked. Health Canada Licensed.

Every October, we shine a spotlight on breast cancer during National Breast Cancer Awareness Month. Thanks to the remarkable innovations in AI (Artificial Intelligence), we have more reasons to raise awareness about advancements in mammography than ever before. AI-powered mammography is revolutionizing care for patients’ breast health by finding cancers...

Computer-Aided Detection (CAD) is a sophisticated FDA-approved technology that helps radiologists identify characteristics that may be associated with various forms of cancer. By using iCAD patented algorithms to mark suspicious areas, CAD serves as a “second pair of eyes” and acts very much like a “spell checker” to identify characteristics...

Using U.S. guidelines, ProFound AI Risk found 14% of women studied who had a negative screen hadalmost 20 times higher risk of developing breast cancer in the next year than the general risk population iCAD recently announced that promising clinical research supporting ProFound AI® Risk for Digital Breast Tomosynthesis (DBT)...

Clinically Proven Technology Enhances Breast Cancer Detection, Improves Accuracy Navicent Health recently announced that they have added the latest development in the fight against breast cancer – iCAD’s ProFound AI for digital breast tomosyntheses (DBT), also known as 3D mammography – to their Mammography Program. ProFound AI for DBT was...

According to the International Agency for Research on Cancer, in 2018 breast cancer accounted for 26.4 percent of all new cancer cases in European women.[i] Europe’s radiologist shortage, particularly in Scotland and the United Kingdom, where the shortage is dire, makes it hard to maintain medical standards.[ii] Without a sufficient...

iCAD, Inc. recently received the “Best New Radiology Solution” Award for the ProFound AI™ platform in the 2019 MedTech Breakthrough Awards Program. The program recognizes the top companies and solutions in the global health and medical technology industries; this year, over 3,500 nominations were considered from more than 15 countries...